Merit Medical Systems reported $1.04B in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
3M USD 16.39B 298M Dec/2025
Abbott USD 26B 1.16B Dec/2025
AngioDynamics USD 161.35M 4.69M Sep/2025
Anika Therapeutics USD 103.36M 1.77M Dec/2025
AtriCure USD 322.52M 21.41M Dec/2025
Baxter International USD 6.87B 61M Dec/2025
Becton, Dickinson and Co. USD 9.19B 66M Dec/2025
Boston Scientific USD 8.79B 759M Dec/2025
Cooper Companies USD 2.13B 27.4M Dec/2025
Dexcom USD 4.03B 1.19B Dec/2025
Edwards Lifesciences USD 6.36B 218.3M Sep/2025
Globus Medical USD 2.13B 201.25M Dec/2025
Haemonetics USD 943.67M 43.99M Dec/2025
Hologic USD 3.84B 175.3M Dec/2025
ICU Medical USD 1.19B 16.74M Dec/2025
Insulet USD 1.91B 54.6M Dec/2025
Integra LifeSciences USD 1.16B 15.96M Dec/2025
J&J USD 55.62B 1.01B Dec/2025
Medtronic USD 24.07B 75M Dec/2025
Merit Medical Systems USD 1.04B 54.62M Dec/2025
Olympus JPY 652.65B 47.58B Dec/2025
Pfizer USD 46.92B 3.22B Sep/2025
STAAR Surgical USD 311.54M 9.66M Dec/2025
Stryker USD 14.76B 1.04B Dec/2025
Surmodics USD 75.99M 5.31M Jun/2025
Tandem Diabetes Care USD 618.14M 1.2M Dec/2025
Teleflex USD 1.94B 47.65M Dec/2025
Terumo JPY 815.56B 71.48B Dec/2025
Zimmer Biomet Holdings USD 5.12B 715M Dec/2025